WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer, Health highlights the critical role of patients, as 4,000 hospitals in the US react to public reporting of sepsis quality scores on Medicare’s portal, Hospital Compare, which poses potential reputational and financial risks. Sepsis now accounts for more than 12 percent of all hospital readmissions—far exceeding rates of heart disease, pneumonia and chronic obstructive pulmonary disease (COPD). As healthcare providers come together in the fight against the deadly condition, Wolters Kluwer is providing educational materials and tailored solutions for fighting sepsis that arm stakeholders across the care continuum—whether they are clinicians, patients or their families.
“Our efforts to fight sepsis are focused on delivering the best outcomes for patients,” said Diana Nole, CEO, Wolters Kluwer, Health. “We are on a mission to help hospitals detect sepsis earlier through a combination of intuitive technologies, point-of-care interventions and evidence-based practice guidelines so clinicians are alerted to the signs of sepsis and begin treatment as quickly as possible. Secondly, to avoid recurrences and readmissions, we want to equip healthcare organizations with effective ways to engage and educate patients treated for sepsis after leaving the hospital.”
Beyond the Hospital: Empowering Patients and Families in Tackling Sepsis
Recognizing the importance of empowering patients to manage their conditions longer-term, Emmi® patient engagement solutions from Wolters Kluwer offer sepsis information that helps patients, family members and caregivers gain a better understanding of sepsis symptoms and risks.
Effective sepsis care outside the hospital can help prevent recurrences and can keep patients from being readmitted. Emmi patient-centered programs stress self-care, demonstrate how to prevent and recognize infection, emphasize the importance of adherence to medication instructions, and provide guidance on when to check in with a primary care provider.
An End-to-End Approach to Sepsis
While often overlooked, patients play a pivotal role in ensuring positive outcomes from sepsis. This end-to-end approach enables Wolters Kluwer to prepare healthcare organizations to better manage sepsis risks. At the point of care, Wolters Kluwer is leveraging its deep knowledge base along with cutting-edge data science and artificial intelligence (AI) to harness hundreds of patient data points, mine and process them so patterns and anomalies are identified in real-time, hours before more overt symptoms become clear to clinical staff. “AI can help us get ahead of sepsis by providing deeper insights early, to identify those likely to develop sepsis or who may be at risk of readmission,” added Nole. “That’s where we’re headed and it’s powerful, given what’s at stake.”
Supporting Clinicians and Families during Sepsis Awareness Month
To commemorate Sepsis Awareness Month, Wolters Kluwer recently launched a one-stop Sepsis Resource Center with current information on sepsis-related policy, solutions for healthcare systems, tools and other resources. The Center contains:
- Access to the Lippincott NursingCenter® which features an informative Signs of Sepsis Infographic as well as updated treatment guidelines and educational materials tailored to nurses.
- Information on the new Hour-1 bundle, patient education and engagement, and revised guidance on sepsis.
- Links to current, evidence-based research on sepsis available through Ovid® and UpToDate®.
- Blogs, webinars and an executive summary on new CMS public reporting on sepsis published by the Wolters Kluwer POC AdvisorTM team.
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global provider of professional information, software solutions, and services for physicians, nurses, accountants, lawyers, tax specialists, and finance, audit, compliance, and regulatory sectors.
The company provides expert solutions—a combination of deep domain knowledge with specialized technology and services—that help professionals navigate change, solve complex problems, and deliver impact in their respective fields.
Headquartered in Alphen aan den Rijn, the Netherlands, Wolters Kluwer holds market-leading positions in 40 countries globally, represents customers across 180 countries and employs 19,000 people worldwide. In 2017, it reported annual revenues of €4.4 billion.
Wolters Kluwer is a leading global provider of trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.